Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuti Chernajovsky

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Molecular Membrane Biology|September 13, 2005
Regulation of expression and function of Lck tyrosine kinase by high cell densityPatricia Ozegbe, Yuti Chernajovsky, Panagiotis S Kabouridis
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2003
Interferon-beta gene therapy for the treatment of arthritisYuti Chernajovsky, Hanna Dreja, Kostas Triantaphyllopoulos, et al.
Nature Reviews. Immunology|October 2, 2004
Gene therapy for autoimmune diseases: quo vadis?Yuti Chernajovsky, David J Gould, Osvaldo L Podhajcer
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|November 8, 2002
Advances in understanding the genetic basis of rheumatoid arthritis and osteoarthritis: implications for therapyYuti Chernajovsky, Paul G Winyard, Panagiotis S Kabouridis
Nature Biotechnology|October 7, 2003
Targeting cytokines to inflammation sitesGill Adams, Sandrine Vessillier, Hanna Dreja, et al.
The Journal of Gene Medicine|April 5, 2002
Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope proteinAlexander E Annenkov, Gordon M Daly, Yuti Chernajovsky
International Immunology|April 17, 2003
Clustering of immunoreceptor tyrosine-based activation motif-containing signalling subunits in CD4(+) T cells is an optimal signal for IFN-gamma production, but not for the production of IL-4Alexander E Annenkov, Gordon M Daly, Thomas Brocker, et al.
Trends in Molecular Medicine|June 5, 2004
Methods for targeting biologicals to specific disease sitesAhuva Nissim, Yarunnessa Gofur, Sandrine Vessillier, et al.
Arthritis Research & Therapy|January 27, 2007
Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritisDavid Gould, Nasim Yousaf, Rewas Fatah, et al.
Regenerative Medicine|May 1, 2007
Engineering stem cells for therapyMarinela Mendez-Pertuz, Chris Hughes, Alex Annenkov, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Molecular Membrane Biology|September 13, 2005
Regulation of expression and function of Lck tyrosine kinase by high cell densityPatricia Ozegbe, Yuti Chernajovsky, Panagiotis S Kabouridis
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2003
Interferon-beta gene therapy for the treatment of arthritisYuti Chernajovsky, Hanna Dreja, Kostas Triantaphyllopoulos, et al.
Nature Reviews. Immunology|October 2, 2004
Gene therapy for autoimmune diseases: quo vadis?Yuti Chernajovsky, David J Gould, Osvaldo L Podhajcer
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|November 8, 2002
Advances in understanding the genetic basis of rheumatoid arthritis and osteoarthritis: implications for therapyYuti Chernajovsky, Paul G Winyard, Panagiotis S Kabouridis
Nature Biotechnology|October 7, 2003
Targeting cytokines to inflammation sitesGill Adams, Sandrine Vessillier, Hanna Dreja, et al.
The Journal of Gene Medicine|April 5, 2002
Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope proteinAlexander E Annenkov, Gordon M Daly, Yuti Chernajovsky
International Immunology|April 17, 2003
Clustering of immunoreceptor tyrosine-based activation motif-containing signalling subunits in CD4(+) T cells is an optimal signal for IFN-gamma production, but not for the production of IL-4Alexander E Annenkov, Gordon M Daly, Thomas Brocker, et al.
Trends in Molecular Medicine|June 5, 2004
Methods for targeting biologicals to specific disease sitesAhuva Nissim, Yarunnessa Gofur, Sandrine Vessillier, et al.
Arthritis Research & Therapy|January 27, 2007
Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritisDavid Gould, Nasim Yousaf, Rewas Fatah, et al.
Regenerative Medicine|May 1, 2007
Engineering stem cells for therapyMarinela Mendez-Pertuz, Chris Hughes, Alex Annenkov, et al.
Pageof 5